MedTrace Logo

Oral Iron Supplementation on Alternate vs. Consecutive Days for Iron Deficiency Anemia in Pregnancy

NCT06492512 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-04-24

No results posted yet for this study

Summary

This will be a randomized clinical trial. Enrolled subjects will be randomized (1:1) into two study arms to receive either daily (Group 1) or alternate day (Group 2) supplementation with one oral pill containing ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill.

Conditions

  • Iron-deficiency Anemia (IDA)
  • Pregnancy

Interventions

DRUG

daily ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill

ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill daily

DRUG

alternate day ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill

ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill every other day

Sponsors & Collaborators

  • Southern Illinois University

    lead OTHER

Principal Investigators

  • Yahia Zeino, MD · Southern Illinois University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-27
Primary Completion
2028-07-01
Completion
2029-07-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06492512 on ClinicalTrials.gov